In recent years, Lilly’s top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, Zepbound (for weight loss) and Mounjaro (for diabetes). But a GLP-1 drug in …
Why Eli Lilly’s Stock Could Be Gearing Up for a Big Rally
view original post